Cidara Therapeutics Inc (CDTX)
19.00
+1.55
(+8.88%)
USD |
NASDAQ |
Nov 22, 11:13
Cidara Therapeutics Price to Book Value: 1.158 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.063 |
| November 20, 2024 | 0.9214 |
| November 19, 2024 | 0.9525 |
| November 18, 2024 | 0.9117 |
| November 15, 2024 | 0.8757 |
| November 14, 2024 | 0.8824 |
| November 13, 2024 | 0.8471 |
| November 12, 2024 | 0.8197 |
| November 11, 2024 | 0.8136 |
| November 08, 2024 | 0.8227 |
| November 07, 2024 | 0.7989 |
| November 06, 2024 | 0.8081 |
| November 05, 2024 | 0.8081 |
| November 04, 2024 | 0.7941 |
| November 01, 2024 | 0.7977 |
| October 31, 2024 | 0.7922 |
| October 30, 2024 | 0.7819 |
| October 29, 2024 | 0.816 |
| October 28, 2024 | 0.7599 |
| October 25, 2024 | 0.7679 |
| October 24, 2024 | 0.6801 |
| October 23, 2024 | 0.6886 |
| October 22, 2024 | 0.6935 |
| October 21, 2024 | 0.6838 |
| October 18, 2024 | 0.6862 |
| Date | Value |
|---|---|
| October 17, 2024 | 0.6795 |
| October 16, 2024 | 0.6545 |
| October 15, 2024 | 0.6198 |
| October 14, 2024 | 0.6277 |
| October 11, 2024 | 0.6466 |
| October 10, 2024 | 0.6411 |
| October 09, 2024 | 0.6612 |
| October 08, 2024 | 0.6527 |
| October 07, 2024 | 0.6783 |
| October 04, 2024 | 0.6643 |
| October 03, 2024 | 0.6521 |
| October 02, 2024 | 0.6429 |
| October 01, 2024 | 0.6466 |
| September 30, 2024 | 0.6551 |
| September 27, 2024 | 0.5773 |
| September 26, 2024 | 0.58 |
| September 25, 2024 | 0.5816 |
| September 24, 2024 | 0.5789 |
| September 23, 2024 | 0.5843 |
| September 20, 2024 | 0.6058 |
| September 19, 2024 | 0.63 |
| September 18, 2024 | 0.6246 |
| September 17, 2024 | 0.6251 |
| September 16, 2024 | 0.6343 |
| September 13, 2024 | 0.6418 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3929
Minimum
Jul 11 2024
68.91
Maximum
Apr 01 2021
7.988
Average
4.177
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.252 |
| Arbutus Biopharma Corp | 6.187 |
| GlycoMimetics Inc | 1.790 |
| FibroGen Inc | -- |
| Cue Biopharma Inc | 2.660 |
Price to Book Value Related Metrics
| PS Ratio | 1.561 |
| PEG Ratio | -0.0010 |
| Price | 19.00 |
| Earnings Yield | -133.5% |
| Market Cap | 133.89M |
| PEGY Ratio | -0.0010 |